Among 34 euthyroid women diabetic patients, six (17.6%) had both antibodies negative, 11 (32.4%) had only anti-TPO positivity, three (8.8%) had only anti-TG-positivity, and 14 (41.2%) had both antibodies positive.20 In our study, 62 (80.5%) of the women patients with Type-II DM had both antibodies negative, 7 (9.1%) had only anti-TPO positive, two (2.6%) had only anti-TG-positivity, and 6 (7.8%) had both antibodies positive. This evidence concerns the gene TPO and diabetes mellitus.